How a French Cosmetics Brand Registered 50 Products in China in 6 Months: Case Study

China’s cosmetics regulatory landscape underwent a fundamental transformation with the implementation of the Cosmetic Supervision and Administration Regulation (CSAR) in 2021. For foreign cosmetics brands, the new regulation introduced a registration and notification system that promised faster market access for lower-risk products while maintaining rigorous safety evaluation requirements for higher-risk categories. In practice, however, the transition period created significant uncertainty, with many brands reporting registration timelines of 8–14 months for individual products.

This case study examines how a French cosmetics brand—specialising in natural-ingredient skin care and body care products—achieved the registration of 50 distinct products with the National Medical Products Administration (NMPA) within 6 months, a feat that positioned the brand for rapid growth in China’s competitive cosmetics market. The brand, referred to here as Provence Soins Naturels (PSN), was founded in Aix-en-Provence in 2005 and entered the Chinese market in 2022 with an initial portfolio of 8 products.

The Brand and Its China Ambitions

PSN specialises in natural-ingredient cosmetics using lavender, olive oil, shea butter, and other Provencal raw materials. The brand’s product portfolio spans moisturisers, serums, cleansers, sun care products, body lotions, hand creams, and lip care products. PSN’s products are positioned in the premium segment, with retail prices ranging from EUR 18 for hand creams to EUR 85 for anti-ageing serums.

PSN entered China through cross-border e-commerce (CBEC) in 2022, which allowed the brand to test the market without full NMPA registration for most products. By 2023, CBEC sales had reached CNY 28 million annually, and the brand’s Chinese distribution partner identified strong potential for growth through domestic retail channels—a channel that requires full NMPA registration for all products.

The decision to pursue full registration for 50 products was driven by retail channel requirements. Major Chinese cosmetics retailers and e-commerce platforms including Tmall Global’s domestic channel, JD.com, and Sephora China require NMPA registration for products sold through their domestic retail operations. PSN’s distribution partner estimated that full domestic retail access would increase annual China revenue to CNY 80–100 million within 24 months.

Understanding China’s Cosmetics Registration Framework

Under CSAR, cosmetics products are classified into two categories for regulatory purposes:

Special cosmetics include products with specific functions such as sun protection, whitening, hair dyeing, perm products, and anti-hair loss products. These require formal NMPA registration and can take 8–14 months to register due to the requirement for full safety testing including human efficacy testing.

General cosmetics (also called non-special cosmetics) include most daily-use products such as moisturisers, cleansers, body lotions, and makeup products. These require NMPA notification (filing) rather than full registration, with a typical processing time of 2–5 months.

PSN’s product portfolio included 12 special cosmetics (mostly sun care products) and 38 general cosmetics. The registration strategy needed to address both categories efficiently within the 6-month target.

The Core Challenge: Processing 50 Products Efficiently

The principal challenge PSN faced was not the regulatory requirements themselves but the operational complexity of processing 50 products simultaneously. Each product required separate documentation, safety testing, formula review, label review, and administrative submission. The total workload was estimated at approximately 2,500 person-hours of regulatory work, which would require a dedicated team of 4–5 regulatory specialists working full-time for 6 months.

Additional challenges included:

• Safety testing capacity: CNCA-accredited cosmetics testing laboratories faced capacity constraints, with typical lead times of 8–12 weeks for general cosmetics testing and 14–20 weeks for special cosmetics testing
• Formula documentation consistency: PSN’s product formulations needed to be translated into the standardised Chinese INCI (International Nomenclature of Cosmetic Ingredients) format, with careful attention to ingredient names, concentrations, and functions
• Label compliance: Chinese cosmetics labelling requirements under GB 5296.3 include specific display requirements for ingredient lists, warning statements, production dates, and expiry information that differ from EU requirements
• Coordinated testing schedules: With 50 products requiring safety testing, efficient laboratory scheduling was critical to avoid bottlenecks

Strategy: The Three-Wave Approach

PSN developed a three-wave registration strategy designed to maximise efficiency while maintaining compliance quality:

Wave 1 — Fast-Track General Cosmetics (Months 1–3)

PSN prioritised 20 general cosmetics (moisturisers, cleansers, body lotions) that were already selling well through CBEC and had established consumer demand. These products required only NMPA notification (not full registration) and could be processed relatively quickly. PSN submitted all 20 product dossiers within the first 8 weeks, leveraging batch processing of similar formulation types to reduce per-product documentation effort.

The key efficiency driver in Wave 1 was formulation grouping. PSN identified 4 formulation families within the 20 products, with each family sharing a common base formulation and differing only in fragrance and active ingredient concentration. By creating standardised documentation templates for each formulation family, the regulatory team reduced per-product documentation time by approximately 60% compared to treating each product independently.

Wave 2 — Complex General Cosmetics (Months 2–5)

The second wave covered 18 general cosmetics with more complex formulations, including products containing active ingredients requiring additional safety data, products with novel ingredient combinations, and products requiring special label reviews. These products required more extensive safety documentation and longer testing periods.

PSN submitted the Wave 2 products in two batches of 9, spaced 6 weeks apart. This staggered approach allowed the regulatory team to allocate documentation resources efficiently while maintaining steady progress through the testing pipeline.

Wave 3 — Special Cosmetics (Months 3–6)

The 12 special cosmetics (sun care products) required the most extensive regulatory work, including human efficacy testing for SPF and PA ratings, stability testing, and full NMPA registration rather than notification. PSN initiated testing for these products in Month 2, before the Wave 1 submissions were complete, to allow the longest possible testing window.

PSN selected a single CNCA-accredited testing laboratory in Shanghai to handle all special cosmetics testing, negotiating a volume discount and dedicated testing time slots. This consolidated approach reduced testing lead time from an estimated 18 weeks to 12 weeks for the special cosmetics.

Operational Execution: Building the Regulatory Machine

PSN’s operational execution involved several key components:

Dedicated regulatory team: PSN hired a China regulatory affairs manager based in Shanghai, supported by a team of three regulatory specialists. The team was supplemented by a Paris-based technical coordinator who managed communication with the French R&D team and sourced raw material safety data from European suppliers.

Standardised documentation system: PSN developed a comprehensive documentation template system covering all required NMPA submission documents. Each template was pre-approved by the Shanghai regulatory team and included standardised language for common regulatory statements, reducing the need for individual document review.

Centralised testing management: A single project manager at PSN’s Shanghai office coordinated all testing activities across three CNCA-accredited laboratories. The project manager maintained a master testing schedule that tracked sample submission dates, expected completion dates, and actual results for all 50 products.

Parallel processing model: PSN implemented a parallel processing model in which formulation review, label development, safety testing, and administrative documentation were handled by different team members simultaneously rather than sequentially. This model reduced the per-product processing time by approximately 40% compared to a sequential approach.

Testing Strategy and Laboratory Management

Testing capacity was one of the most significant constraints in the registration programme. PSN engaged three CNCA-accredited cosmetics testing laboratories—two in Shanghai and one in Guangzhou—to distribute the workload and mitigate the risk of laboratory-specific delays.

For general cosmetics, PSN used a consolidated testing approach: products from the same formulation family were tested as a group, with the most comprehensive testing performed on a representative product from each family and reduced-scope testing for other products in the same family. This approach reduced total testing costs by approximately 30% while satisfying NMPA’s safety data requirements.

For special cosmetics, PSN faced the additional requirement of human efficacy testing for sun protection products. The company selected a Shanghai laboratory with specialised experience in SPF and PA testing under Chinese GB standards. The human efficacy testing protocol required 10 healthy volunteers per product, with a 2-week testing cycle per batch. PSN scheduled the 12 special cosmetics across 4 testing batches, completing all human efficacy testing within 16 weeks.

Regulatory Milestones and Timeline

Cost Analysis

The total programme cost for registering 50 products in 6 months was approximately EUR 285,000. The breakdown by category was:

• Regulatory team salaries and overhead: EUR 110,000 (4 full-time staff for 6 months)
• Safety testing and human efficacy testing: EUR 95,000
• Consultancy and legal support: EUR 40,000
• Document preparation, translation, and notarisation: EUR 25,000
• Miscellaneous (samples, shipping, courier): EUR 15,000

The per-product cost averaged EUR 5,700, compared to an industry average of EUR 8,000–12,000 per product for cosmetic brands of similar size. The cost efficiency was driven by the batch processing approach, formulation family grouping, and consolidated laboratory agreements.

Key Success Factors

Results and Market Impact

PSN achieved full NMPA registration for all 50 products within 6 months of programme initiation. This resulted in:

• Domestic retail channel access: Products launched on Tmall Domestic, JD.com, and Sephora China within 2 months of receiving registration
• Revenue growth: China domestic retail revenue reached CNY 45 million in the first 12 months, with projected growth to CNY 85 million in year two
• Brand presence: PSN expanded from online-only CBEC to 3 major retail chains and 12 specialty cosmetics stores
• Competitive advantage: The rapid registration programme positioned PSN as one of the fastest-growing mid-tier French cosmetics brands in China during the 2024–2025 period

Lessons for Other Foreign Cosmetics Brands

PSN’s experience offers several actionable lessons for foreign cosmetics brands planning to register products in China:

Invest before you need to. The regulatory team was hired and operational 2 months before the first product submission. Attempting to register products without dedicated in-country regulatory expertise significantly increases timeline risk.

Group products by formulation, not by brand or marketing category. Formulation families are the natural unit of efficient regulatory processing. Organising work around formulation chemistry rather than product marketing categories can dramatically improve efficiency.

Start special products early. Special cosmetics (sun care, whitening, anti-hair loss, etc.) require significantly more testing time. Initiate their testing programme at least 3–4 months before the target submission date, even while other product documentation is still being prepared.

Build laboratory relationships before you need them. PSN’s ability to negotiate dedicated testing time slots was based on relationships established during the pre-programme phase. Laboratories with full capacity will not prioritise unknown clients during peak periods.

Plan for quality, not speed. PSN’s speed was achieved through efficiency, not by cutting corners. Every product dossier was reviewed by at least two team members before submission. Rejection rates due to incomplete or incorrect documentation were below 5%, well below the industry average of 20–30%.